KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like Bay Area's OncoMed Tanks Some More as GlaxoSmithKline Walks Away From R&D Pact July 10, 2017 Despite Recent Layoffs, Eli Lilly to Invest $850 Million in U.S. Operations March 23, 2017 Top 10 Best Locations for Life Science Jobs in the World October 25, 2017
